Diagnosis and management of differentiated thyroid cancer using molecular biology (Q38081125)

28 August 2017

Diagnosis and management of differentiated thyroid cancer using molecular biology (English)

1 reference

differentiated thyroid carcinoma

28 August 2017

0 references

1 reference

2

Robert L Ferris

1 reference

28 August 2017

Robert L Witt

1

1 reference

28 August 2017

Edmund A Pribitkin

3

1 reference

28 August 2017

Steven I Sherman

4

1 reference

28 August 2017

David L Steward

5

1 reference

28 August 2017

Yuri E Nikiforov

6

1 reference

28 August 2017

language of work or name

English

0 references

publication date

12 February 2013

1 reference

28 August 2017

1 reference

28 August 2017

123

1 reference

28 August 2017

1059-1064

1 reference

28 August 2017

4

1 reference

Changing trends in thyroid practice: understanding nodular thyroid disease

28 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

Galectin-3 and HBME-1 expression in well-differentiated thyroid tumors with follicular architecture of uncertain malignant potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

Diagnostic usefulness of tumor markers in the thyroid cytological samples extracted by fine-needle aspiration biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

Molecular analysis of thyroid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

BRAF mutation in thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

Prevalence of RET/PTC rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

Prevalence of activating ras mutations in morphologically characterized thyroid nodules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

Light-directed, spatially addressable parallel chemical synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

Perspectives and limitations of microarray-based gene expression profiling of thyroid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

Significance analysis of microarrays applied to the ionizing radiation response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

Molecular diagnostics and predictors in thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

Reflex BRAF testing in thyroid fine-needle aspiration biopsy with equivocal and positive interpretation: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

BRAFV600E mutation analysis in fine-needle aspiration cytology specimens for evaluation of thyroid nodule: a large series in a BRAFV600E-prevalent population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

Detection of papillary thyroid carcinoma by analysis of BRAF and RET/PTC1 mutations in fine-needle aspiration biopsies of thyroid nodules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

Molecular classification of thyroid nodules using high-dimensionality genomic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

Surgical results of thyroid nodules according to a management guideline based on the BRAF(V600E) mutation status

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

Reoperative central compartment dissection for patients with recurrent/persistent papillary thyroid cancer: efficacy, safety, and the association of the BRAF mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

BRAF in primary and recurrent papillary thyroid cancers: the relationship with (131)I and 2-[(18)F]fluoro-2-deoxy-D-glucose uptake ability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

MicroRNA expression profiles in thyroid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.23838

21 January 2018

Identifiers

DOI

10.1002/LARY.23838

1 reference

28 August 2017

1 reference